Oral Administration of High Molecular Weight Hyaluronan (900 kDa) Controls Immune System via Toll-like Receptor 4 in the Intestinal Epithelium
Open Access
- 6 August 2010
- journal article
- Published by Elsevier BV in Journal of Biological Chemistry
- Vol. 285 (32), 24751-24758
- https://doi.org/10.1074/jbc.m110.104950
Abstract
No abstract availableKeywords
This publication has 31 references indexed in Scilit:
- Engagement of CD44 by hyaluronan suppresses TLR4 signaling and the septic response to LPSMolecular Immunology, 2009
- Critical Role of P-Selectin and Lymphocyte Function Antigen-1 in Radiation-Induced Leukocyte-Endothelial Cell Interactions in the ColonDiseases of the Colon & Rectum, 2007
- TLR signaling at the intestinal epithelial interfaceInnate Immunity, 2003
- TLR signaling at the intestinal epithelial interfaceInnate Immunity, 2003
- Responsiveness of intestinal epithelial cell lines to lipopolysaccharide is correlated with Toll-like receptor 4 but not Toll-like receptor 2 or CD14 expressionInternational Journal of Colorectal Disease, 2003
- TLR4 and MD-2 Expression Is Regulated by Immune-mediated Signals in Human Intestinal Epithelial CellsPublished by Elsevier BV ,2002
- Oligosaccharides of Hyaluronan Activate Dendritic Cells via Toll-like Receptor 4The Journal of Experimental Medicine, 2002
- IL-12 Enhances Lymphoaccumulation by Suppressing Cell Death of T Cells in MRL- lpr/lpr MiceJournal of Autoimmunity, 2001
- Basic FGF and FGF receptor 1 are expressed in microglia during experimental autoimmune encephalomyelitis: Temporally distinct expression of midkine and pleiotrophenGlia, 1998
- Lymphoproliferation disorder in mice explained by defects in Fas antigen that mediates apoptosisNature, 1992